Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl or sufentanil with propofol for hemodynamic response to laryngoscopy and endotracheal intubation
IRCT20200825048515N18Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial comparing Fentanyl + propofol, Sufentanil + propofol and Propofol + normal saline control (3 arms). Primary endpoints: Heart rate and Blood pressure. Started Nov 2020; status: completed.
02
Drugs
fentanylsufentanilpropofol
Beyond the preview
Go deeper on IRCT20200825048515N18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200825048515N18.